(Q34512169)

2 August 2017

Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470. (English)

1 reference

2 August 2017

1 reference

1 reference

2

S A Grupp

1 reference

2 August 2017

S Shusterman

1

1 reference

PubMed ID

11107144

2 August 2017

J M Maris

series ordinal

3

1 reference

2 August 2017

1 December 2000

1 reference

2 August 2017

Pediatric Blood Cancer

1 reference

2 August 2017

35

1 reference

2 August 2017

673-676

1 reference

2 August 2017

6

1 reference

Molecular biology of neuroblastoma

2 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C673%3A%3AAID-MPO41%3E3.0.CO%3B2-O

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C673%3A%3AAID-MPO41%3E3.0.CO%3B2-O

Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C673%3A%3AAID-MPO41%3E3.0.CO%3B2-O

The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C673%3A%3AAID-MPO41%3E3.0.CO%3B2-O

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C673%3A%3AAID-MPO41%3E3.0.CO%3B2-O

TNP-470 antiangiogenic therapy for advanced murine neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C673%3A%3AAID-MPO41%3E3.0.CO%3B2-O

The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C673%3A%3AAID-MPO41%3E3.0.CO%3B2-O

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C673%3A%3AAID-MPO41%3E3.0.CO%3B2-O

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C673%3A%3AAID-MPO41%3E3.0.CO%3B2-O

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C673%3A%3AAID-MPO41%3E3.0.CO%3B2-O

Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C673%3A%3AAID-MPO41%3E3.0.CO%3B2-O

Angiostatin induces and sustains dormancy of human primary tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C673%3A%3AAID-MPO41%3E3.0.CO%3B2-O

10.1002/1096-911X(20001201)35:6<673::AID-MPO41>3.0.CO;2-O

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11107144